Table 1

Characteristics of Study Cohort

CharacteristicIncome Quintilea
Q1 (Lowest)
(n = 7,915)
Q2
(n = 7,362)
Q3
(n = 6,685)
Q4
(n = 6,679)
Q5 (Highest)
(n = 6,100)
Hospitalized, %3.62.51.71.31.0
Patient demographics
 Sex, male, %39.141.542.444.444.5
 Age, mean (SD), y46.6 (14.6)46.4 (14.5)47.2 (14.5)47.0 (14.3)46.7 (14.4)
Comorbidity level (major ADGs)b
 Low (0–1), %57.367.569.871.774.3
 Medium (2–3), %35.228.026.725.023.3
 High (≥4), %7.54.53.53.32.4
Ambulatory care usec
 Physician visits, mean No. (SD)29.1 (23.1)22.6 (18.6)22.1 (18.3)20.8 (17.1)20.0 (16.5)
 Usual physician index, mean (SD)d0.59 (0.23)0.63 (0.23)0.64 (0.22)0.64 (0.22)0.62 (0.22)
 Received influenza vaccine, %33.931.332.432.632.6
 Referred to specialist, %7.36.67.15.97.1
Usual physician characteristicse
 Type, family physician, %91.692.391.791.890.7
 Payment, fee for service, %96.697.197.697.897.7
 Sex, male, %80.974.373.772.370.3
Time practicing in Manitoba
 1–9 y27.924.421.521.821.9
 10–17 y27.924.526.324.822.7
 ≥18 y44.251.152.253.555.4
Training, international, %41.039.038.036.535.2
Daily patient load, mean No. (SD)34.8 (16.0)33.9 (14.3)33.7 (14.0)33.0 (13.3)32.0 (12.7)
  • ADG = aggregated diagnosis group.

    Note: Data only available starting in 1991.

  • a All differences between groups were significant at P <.05 on analysis of variance or χ2 analysis.

  • b Of 8 major ADGs during 3 years: ADG3, ADG4, ADG9, ADG11, ADG16, ADG22, ADG25, or ADG32.

  • c For the 3-year period before index hospitalization or median time to that event; 1-year period for influenza vaccine.

  • d Possible range: 0 to 1.0. Higher values indicate greater continuity of care.

  • e At the patient level; for example, 80.9% of patients in Q1 had a male usual physician.